Who owns PHOENIX BIOTECH ACQUISITION CLASS A?

Tip: Access positions for across all investors

Analyze quarterly positions in Phoenix Biotech Acquisition Class A with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Phoenix Biotech Acquisition Class A stock

Who bought or sold PHOENIX BIOTECH ACQUISITION CLASS A this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Arch Venture Corp 9.4M $564k 550% Dec 2024
 View chart
Honkamp Krueger Financial Services 2.6M $155k 90% Dec 2024
 View chart
Cubist Systematic Strategies 333k $20k 100% Dec 2024
 View chart
JustInvest 235k $14k 100% Dec 2024
 View chart
Goldman Sachs Group 163k $9.7k 100% Dec 2024
 View chart
Selkirk Management LLC_____ 121k $7.3k 0% Dec 2024
 View chart
Tower Research Capital 74k $4.4k 1384% Dec 2024
 View chart
Millennium Management 63k $3.8k 100% Dec 2024
 View chart
Jane Street 58k $3.4k 1% Dec 2024
 View chart
Revolve Wealth Partners 33k $2.0k 100% Dec 2024
 View chart
FNY Investment Advisers 26k $157k 0% Dec 2024
 View chart
HBK Sorce Advisory 26k $1.6k 100% Dec 2024
 View chart
SG Americas Securities 26k $2.0k 100% Dec 2024
 View chart
Guidance Point Advisors 19k $1.1k 100% Dec 2024
 View chart
Birchview Capital 13k $778.320000 0% Dec 2024
 View chart
Bank of America Corporation 685.00 $41.031500 195% Dec 2024
 View chart
Advisor Group Holdings 400.00 $36.000000 0% Dec 2024
 View chart
Jpmorgan Chase & Co 140.00 $7.994000 6900% Dec 2024
 View chart

Who sold out of Phoenix Biotech Acquisition Class A?

Fund or Company Name Date Sold Shares Held Valued At
Geode Capital Management Sep 2024 157k $15k
Hrt Financial Sep 2024 80k $7.0k
Fifth Lane Capital Sep 2024 77k $6.9k
XTX Topco Sep 2024 57k $5.3k
CI Private Wealth Sep 2024 15k $1.4k
Jump Financial Sep 2024 12k $1.1k
Pineridge Advisors Sep 2024 300.00 $27.990000